How many stocks does LOOMIS SAYLES & CO L P own?

As of Q4 2021, LOOMIS SAYLES & CO L P holds 766 positions in their 13F portfolio.

What is LOOMIS SAYLES & CO L P's largest holding?

NVDA at 5.6% of portfolio, worth $4.6B.

What is LOOMIS SAYLES & CO L P's total portfolio value?

$82.7B as of Q4 2021, tracked across 766 holdings.

Is LOOMIS SAYLES & CO L P a hedge fund?

LOOMIS SAYLES & CO L P is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does LOOMIS SAYLES & CO L P report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has LOOMIS SAYLES & CO L P's portfolio changed in Q4 2021?

View LOOMIS SAYLES & CO L P's latest portfolio changes, new positions, and exits for Q4 2021 on HoldingsIntel.

What is LOOMIS SAYLES & CO L P's investment strategy?

LOOMIS SAYLES & CO L P is classified as a Steady Compounder fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

LOOMIS SAYLES & CO L P

Institutional investor · Portfolio as of Q4 2021

SEC EDGAR SourceSEC Filings

$82.7B

AUM

766

Positions

Q4 2021

Filing

Rating · 2.5

Quarterly Portfolio Change

Activity profile

$ moved · Q4'21

New4%Increased20%Decreased66%Exited9%

Composition

Equity vs derivatives

Equity100%Puts0%Calls0%

Holding period

Avg 2.1 years

<1Q5%1-4Q15%1-2Y17%2Y+63%

Q4 2021 Summary

Active quarter - 62 new positions, 183 exits, 198 increased. Top move: BA (INCREASED, conviction 69). Portfolio: $82.7B across 766 positions.

Portfolio Allocation

Top holdings by portfolio weight

NVDA5.60%

AMZN5.33%

META4.82%

MSFT3.87%

V3.83%

GOOGL3.47%

ORCL3.26%

BA3.26%

CRM3.25%

ADSK2.97%

Other2.81%

Sector Breakdown

Portfolio allocation by GICS sector

Technology29.27%

Communication Services14.70%

Healthcare13.99%

Consumer Cyclical13.31%

Industrials10.29%

Financial Services9.25%

Consumer Defensive4.72%

Unknown1.69%

Basic Materials1.21%

Energy1.20%

Other0.38%

Fund DNA

Behavioral investing profile

Steady Compounder85%- primarily Technology, Communication Services, Healthcare

Compare DNA across all funds

Fund Rating

7-dimension quality assessment

Solid(2.5 / 5.0)

Track Record65

Conviction40

Concentration0

Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

GNRC13Q held

GENERAC HLDGS INC

Avg $55.05 · $13.5M est. P&L

Est. P&L

+541.16%

GLOB13Q held

GLOBANT S A

Avg $73.34 · $92,608 est. P&L

Est. P&L

+329.68%

MSCI13Q held

MSCI INC

Avg $140.62 · $58.8M est. P&L

Est. P&L

+314.98%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings766 positions

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
NVDA NVIDIA CORPORATION	15.7M	$4.6B	5.6%	—	$16.58	+78.11%	12 qtrssince 2019-Q1	Decreased 0
AMZN AMAZON COM INC	1.3M	$4.4B	5.3%	—	$76.41	+120.71%	13 qtrssince 2018-Q4	Decreased 0
META META PLATFORMS INC	11.8M	$4B	4.8%	—	$138.20	+147.45%	13 qtrssince 2018-Q4	Decreased 0
MSFT MICROSOFT CORP	9.5M	$3.2B	3.9%	—	$98.21	+234.31%	13 qtrssince 2018-Q4	Decreased 0
V VISA INC	14.6M	$3.2B	3.8%	—	$131.28	+60.70%	13 qtrssince 2018-Q4	Increased 61
GOOGL ALPHABET INC	990,794	$2.9B	3.5%	—	$53.64	+170.50%	13 qtrssince 2018-Q4	Decreased 0
ORCL ORACLE CORP	30.9M	$2.7B	3.3%	—	$40.87	+103.42%	13 qtrssince 2018-Q4	Decreased 0
BA BOEING CO	13.4M	$2.7B	3.3%	—	$190.56	+6.38%	13 qtrssince 2018-Q4	Increased 69
CRM SALESFORCE INC	10.6M	$2.7B	3.2%	—	$174.87	+44.26%	8 qtrssince 2020-Q1	Decreased 0
ADSK AUTODESK INC	8.7M	$2.5B	3.0%	—	$130.51	+115.85%	13 qtrssince 2018-Q4	Decreased 0
GOOG ALPHABET INC	801,638	$2.3B	2.8%	—	$52.35	+176.83%	13 qtrssince 2018-Q4	Decreased 0
DIS DISNEY WALT CO	13.5M	$2.1B	2.5%	—	$133.78	+13.88%	13 qtrssince 2018-Q4	Increased 67
MNST MONSTER BEVERAGE CORP NEW	19.8M	$1.9B	2.3%	—	$25.12	+89.87%	13 qtrssince 2018-Q4	Decreased 0
REGN REGENERON PHARMACEUTICALS	2.6M	$1.7B	2.0%	—	$352.49	+81.28%	13 qtrssince 2018-Q4	Decreased 0
DE DEERE & CO	4.6M	$1.6B	1.9%	—	$135.73	+138.70%	13 qtrssince 2018-Q4	Decreased 0
NVS ADR NOVARTIS AG	17.9M	$1.6B	1.9%	—	$70.45	+6.09%	13 qtrssince 2018-Q4	Decreased 0
QCOM QUALCOMM INC	8.6M	$1.6B	1.9%	—	$48.19	+246.72%	13 qtrssince 2018-Q4	Decreased 0
SBUX STARBUCKS CORP	12.8M	$1.5B	1.8%	—	$62.76	+67.14%	13 qtrssince 2018-Q4	Decreased 0
VRTX VERTEX PHARMACEUTICALS INC	6.6M	$1.5B	1.8%	—	$186.49	+19.29%	9 qtrssince 2019-Q4	Decreased 0
ILMN ILLUMINA INC	3.6M	$1.4B	1.7%	—	$312.02	+19.79%	8 qtrssince 2020-Q1	Increased 57
Showing 20 of 766 results.746 more with Pro.PROUpgrade to see all →